Virus Infections and Type 1 Diabetes Risk
暂无分享,去创建一个
[1] S. Blomqvist,et al. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[2] I. Shimomura,et al. Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes. , 2010, Endocrine journal.
[3] M. V. von Herrath,et al. 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Viruses, autoimmunity and immunoregulation , 2010, Clinical and experimental immunology.
[4] D. Hober,et al. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host , 2010, Nature Reviews Endocrinology.
[5] H. Hyöty,et al. Evaluation of immunohistochemistry and in situ hybridization methods for the detection of enteroviruses using infected cell culture samples. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[6] J. Galama,et al. Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection. , 2010, Viral immunology.
[7] J. Galama,et al. Phagocytosis of Enterovirus-Infected Pancreatic β-Cells Triggers Innate Immune Responses in Human Dendritic Cells , 2010, Diabetes.
[8] Torben F. Ørntoft,et al. Cytokines Interleukin-1β and Tumor Necrosis Factor-α Regulate Different Transcriptional and Alternative Splicing Networks in Primary β-Cells , 2009, Diabetes.
[9] Cheng-qiang He,et al. Appearance of mosaic enterovirus 71 in the 2008 outbreak of China. , 2009, Virus research.
[10] A. Fowlkes,et al. Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007-2008. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] R. Katoh,et al. Enterovirus Infection, CXC Chemokine Ligand 10 (CXCL10), and CXCR3 Circuit , 2009, Diabetes.
[12] M. Richer,et al. The Innate Immune Response: An Important Partner in Shaping Coxsackievirus-Mediated Autoimmunity , 2009, Journal of Innate Immunity.
[13] M. Richer,et al. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes. , 2009, Autoimmunity reviews.
[14] P. Minor. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication. , 2009, Vaccine.
[15] K. Klingel,et al. Role of enteroviruses in the pathogenesis of type 1 diabetes , 2009, Diabetologia.
[16] N. Morgan,et al. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes , 2009, Diabetologia.
[17] M. Roivainen,et al. Amino acids of coxsackie B5 virus are critical for infection of the murine insulinoma cell line, MIN‐6 , 2009, Journal of medical virology.
[18] O. Vaarala. Leaking gut in type 1 diabetes , 2008, Current opinion in gastroenterology.
[19] J. Echevarría,et al. Molecular characterization of a coxsackievirus A24 variant that caused an outbreak of acute haemorrhagic conjunctivitis in Spain, 2004. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[20] J. Ilonen,et al. Analysis of pancreas tissue in a child positive for islet cell antibodies , 2008, Diabetologia.
[21] M. Roivainen,et al. An enterovirus strain isolated from diabetic child belongs to a genetic subcluster of echovirus 11, but is also neutralised with monotypic antisera to coxsackievirus A9. , 2008, The Journal of general virology.
[22] S. Blomqvist,et al. Eight Years of Experience with Molecular Identification of Human Enteroviruses , 2008, Journal of Clinical Microbiology.
[23] I. Fajardy,et al. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes , 2008, Journal of medical virology.
[24] G. Bussolati,et al. Technical pitfalls potentially affecting diagnoses in immunohistochemistry , 2008, Journal of Clinical Pathology.
[25] K. Kaukinen,et al. Detection of enteroviruses in the intestine of type 1 diabetic patients , 2007, Clinical and experimental immunology.
[26] U. Boggi,et al. Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients , 2007, Proceedings of the National Academy of Sciences.
[27] M. Roivainen. Enteroviruses: new findings on the role of enteroviruses in type 1 diabetes. , 2006, The international journal of biochemistry & cell biology.
[28] H. Hyöty,et al. Molecular Analysis of an Echovirus 3 Strain Isolated from an Individual Concurrently with Appearance of Islet Cell and IA-2 Autoantibodies , 2006, Journal of Clinical Microbiology.
[29] J. Weill,et al. Viral Protein VP4 Is a Target of Human Antibodies Enhancing Coxsackievirus B4- and B3-Induced Synthesis of Alpha Interferon , 2005, Journal of Virology.
[30] G. Palacios,et al. Enteroviruses as agents of emerging infectious diseases , 2005, Journal of NeuroVirology.
[31] J. Ilonen,et al. Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes. , 2005, Diabetes.
[32] R. Lahesmaa,et al. Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets , 2005, Diabetologia.
[33] M. Roivainen,et al. Phenotypic and genetic changes in coxsackievirus B5 following repeated passage in mouse pancreas in vivo , 2005, Journal of medical virology.
[34] K. Klingel,et al. Molecular pathology of inflammatory cardiomyopathy , 2004, Medical Microbiology and Immunology.
[35] K. Klingel,et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells , 2004, Diabetologia.
[36] J. Galama,et al. Molecular and biological analysis of echovirus 9 strain isolated from a diabetic child , 2003, Journal of medical virology.
[37] J. Galama,et al. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains , 2002, Diabetologia.
[38] H. Lankinen,et al. Enterovirus infection can induce immune responses that cross‐react with β‐cell autoantigen tyrosine phosphatase IA‐2/IAR , 2002, Journal of medical virology.
[39] D. Hober,et al. Antibody-Dependent Enhancement of Coxsackievirus B4 Infectivity of Human Peripheral Blood Mononuclear Cells Results in Increased Interferon-α Synthesis , 2001 .
[40] M. Sarvas,et al. Picornavirus proteins share antigenic determinants with heat shock proteins 60/65 , 2000 .
[41] M. Pallansch,et al. Typing of Human Enteroviruses by Partial Sequencing of VP1 , 1999, Journal of Clinical Microbiology.
[42] B. McManus,et al. Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets , 1996, Journal of virology.
[43] Y. Kang,et al. Complete nucleotide sequence of a strain of coxsackie B4 virus of human origin that induces diabetes in mice and its comparison with nondiabetogenic coxsackie B4 JBV strain , 1994, Journal of medical virology.
[44] J. Almond,et al. Complete nucleotide sequence of a beta‐cell tropic variant of coxsackievirus B4 , 1994, Journal of medical virology.
[45] A. Notkins,et al. Virus-induced diabetes in mice. , 1983, Metabolism: clinical and experimental.
[46] T. Onodera,et al. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. , 1979 .
[47] H. Hyöty,et al. Enteroviruses in the pathogenesis of type 1 diabetes , 2010, Seminars in Immunopathology.
[48] M. Roivainen,et al. Vitronectin receptors, alpha v integrins, are recognized by several non-RGD-containing echoviruses in a continuous laboratory cell line and also in primary human Langerhans' islets and endothelial cells. , 2010, The Journal of general virology.
[49] K. Klingel. Molecular Biologic Detection of Virus Infection in Myocarditis and Dilated Cardiomyopathy , 2003 .
[50] A. Brunt,et al. Virus Taxonomy. Seventh Report of the International Committee on Taxomony of Viruses , 1999 .